Charles Schwab’s Arvinas ARVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.51M Buy
542,174
+17,000
+3% +$159K ﹤0.01% 2528
2026
Q1
$5.57M Sell
525,174
-22,302
-4% -$276K ﹤0.01% 2361
2025
Q4
$6.49M Sell
547,476
-62,297
-10% -$680K ﹤0.01% 2332
2025
Q3
$5.2M Buy
609,773
+80,355
+15% +$609K ﹤0.01% 2427
2025
Q2
$3.9M Buy
529,418
+40,179
+8% +$296K ﹤0.01% 2433
2025
Q1
$3.43M Sell
489,239
-46,873
-9% -$735K ﹤0.01% 2425
2024
Q4
$10.3M Buy
536,112
+5,443
+1% +$132K ﹤0.01% 2000
2024
Q3
$13.1M Sell
530,669
-13,834
-3% -$361K ﹤0.01% 1907
2024
Q2
$14.5M Buy
544,503
+16,448
+3% +$524K ﹤0.01% 1853
2024
Q1
$21.8M Buy
528,055
+58,581
+12% +$2.56M 0.01% 1559
2023
Q4
$19.3M Buy
469,474
+39,484
+9% +$923K ﹤0.01% 1619
2023
Q3
$8.45M Buy
429,990
+66,430
+18% +$1.63M ﹤0.01% 1997
2023
Q2
$9.02M Buy
363,560
+4,699
+1% +$121K ﹤0.01% 1951
2023
Q1
$9.8M Sell
358,861
-1,741
-0.5% -$55K ﹤0.01% 1887
2022
Q4
$12.3M Buy
360,602
+7,675
+2% +$323K ﹤0.01% 1736
2022
Q3
$15.7M Buy
352,927
+31,587
+10% +$1.53M 0.01% 1551
2022
Q2
$13.5M Sell
321,340
-7,709
-2% -$387K ﹤0.01% 1665
2022
Q1
$22.1M Buy
329,049
+7,963
+2% +$543K 0.01% 1467
2021
Q4
$26.4M Buy
321,086
+19,316
+6% +$1.57M 0.01% 1367
2021
Q3
$24.8M Buy
301,770
+51,589
+21% +$4.56M 0.01% 1394
2021
Q2
$19.3M Buy
250,181
+19,279
+8% +$1.34M 0.01% 1620
2021
Q1
$15.3M Buy
230,902
+19,268
+9% +$1.47M 0.01% 1715
2020
Q4
$18M Buy
211,634
+40,934
+24% +$1.41M 0.01% 1484
2020
Q3
$4.03M Buy
170,700
+38,020
+29% +$1.1M ﹤0.01% 2179
2020
Q2
$4.45M Buy
132,680
+22,852
+21% +$970K ﹤0.01% 2082
2020
Q1
$4.43M Buy
109,828
+4,048
+4% +$189K ﹤0.01% 1894
2019
Q4
$4.35M Buy
105,780
+28,101
+36% +$823K ﹤0.01% 2090
2019
Q3
$1.67M Buy
77,679
+12,314
+19% +$302K ﹤0.01% 2440
2019
Q2
$1.44M Buy
65,365
+21,709
+50% +$456K ﹤0.01% 2470
2019
Q1
$645K Buy
43,656
+893
+2% +$15.8K ﹤0.01% 2673
2018
Q4
$550K Buy
+42,763
New +$678K ﹤0.01% 2731

Other funds holding ARVN

Charles Schwab's ARVN Position: Q2 2026 in Review

Charles Schwab increased its Arvinas (ARVN) stake by 3.2% in Q2 2026, buying an estimated $159K and bringing the position to 542,174 shares worth $4.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2528.

Charles Schwab first reported a position in ARVN in Q4 2018 and has held it in 31 quarters since. The position peaked at $26.4M in Q4 2021. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Charles Schwab held 542,174 shares of Arvinas worth $4.51M as of Q2 2026.
  • Charles Schwab bought 17,000 Arvinas shares in Q2 2026, an estimated $159K.
  • Arvinas made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2528 holding.
  • Charles Schwab first reported a position in Arvinas in Q4 2018 and has held it in 31 quarters since.
  • Charles Schwab's Arvinas position peaked at $26.4M in Q4 2021.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.